Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients

NCT02160301 Phase 4 WITHDRAWN

The study is a prospective, randomized, open-label comparison of a multimodal regimen and a standard, narcotic-based regimen for postoperative pain control in patients undergoing surgery for an operatively indicated, isolated extremity fracture. The investigators will be measuring pain levels, narcotic use, patient satisfaction, patient reported function, adverse events and fracture union. The investigators hypothesize that this multimodal regimen will lead to improved pain, less narcotic use and improved satisfaction as compared to the standard regimen.

Details

Lead sponsor	University of North Carolina, Chapel Hill
Phase	Phase 4
Status	WITHDRAWN
Start date	2017-11
Completion	2019-12

Conditions

• Post Operative Pain Control

Interventions

• Gabapentin
• Acetaminophen
• Acetaminophen
• Celecoxib
• Dexamethasone
• Oxycodone

Primary outcomes

• Pain — 6 months
  VAS score for pain control, daily for two weeks post op and at all follow up visits for 6 months.
• Narcotic Use — 2 months
  Measurement of both daily narcotic use in milligrams as well as the duration of narcotic treatment in days.
• Patient Satisfaction — 3 months
  Measurement of patient satisfaction with pain control regimen using the American Pain Society's Patient Outcome Questionnaire (APS-POQ).

Countries

United States